KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-Current Debt: 2011-2025

Historic Non-Current Debt for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $1.0 billion.

  • Sarepta Therapeutics' Non-Current Debt fell 8.88% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 8.88%. This contributed to the annual value of $1.1 billion for FY2024, which is 0.41% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Non-Current Debt is $1.0 billion, which was down 9.15% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Non-Current Debt registered a high of $1.5 billion during Q4 2022, and its lowest value of $1.0 billion during Q3 2025.
  • Over the past 3 years, Sarepta Therapeutics' median Non-Current Debt value was $1.1 billion (recorded in 2024), while the average stood at $1.2 billion.
  • In the last 5 years, Sarepta Therapeutics' Non-Current Debt soared by 58.60% in 2021 and then decreased by 26.66% in 2023.
  • Sarepta Therapeutics' Non-Current Debt (Quarterly) stood at $1.1 billion in 2021, then spiked by 40.79% to $1.5 billion in 2022, then declined by 26.66% to $1.1 billion in 2023, then rose by 0.41% to $1.1 billion in 2024, then fell by 8.88% to $1.0 billion in 2025.
  • Its Non-Current Debt was $1.0 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.